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Tuberculosis is a serious respiratory infectious disease, caused by 
Mycobacterium tuberculosis bacteria. It has always represented 
a permanent, serious public health challenge over the course of 
human history, because of its severe epidemiological, clinical and 
societal implications. The present review aims at over-viewing the 
contributions of the Iranian medicine to the control, management 
and treatment of tuberculosis, from the glorious past of the eighth-
ninth centuries to the present, from Ali Abu al-Hasan Ahmad ibn 
Sahl-e Rabban al-Tabari to Rhazes, Avicenna, Jorjani and Abol-
hassan ZiyÃ-Zarifi. However, despite the efforts, tuberculosis and, 
in particular, multidrug-resistant tuberculosis still represent a 
great public health concern in Iran. On the other hand, this coun-
try can capitalize on its millennial, incredibly rich story of major 
achievements in the battle against tuberculosis to develop and 
implement ad hoc public health programs for the control of the 
disorder, including targeted and specialized interventions.
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Introduction
Tuberculosis is a serious respiratory infectious disease, 
caused by Mycobacterium tuberculosis bacteria. It has 
always represented a permanent, serious public health 
challenge over the course of human history, because 
of its severe epidemiological, clinical and societal im-
plications [1]. The present review aims at overviewing 
the contributions of the Iranian medicine to the control, 
management and treatment of tuberculosis, from the 
glorious past of the eighth-ninth centuries to the present. 
Tuberculosis and the glorious past  
of the Iranian medicine
The Iranian medicine has a rich, glorious millennial 
past. Ali Abu al-Hasan Ahmad ibn Sahl-e Rabban al-
Tabari (born in Merv, in the Khorasan, or in Toranja, in 
the province of Tabaristan in 783, 808, 810 or 838, and 
dead in Baghdad or in Samarra, in 855, 858, 864 or 870, 
according to other scholars) was an erudite Persian Mus-
lim scholar, son of a prominent Syrian Christian phy-
sician, Sahl ibn Bishr, who was also a mathematician 
and astronomer. al-Tabari was erroneously considered 
Jewish by some researchers because of the nickname 
of the father (“Rabban”, meaning “master”), whereas 
other scholars thought he was Christian (“al-Katib al-
Nasrani”, meaning “the Christian writer”). According to 
other sources, he was Zoroastrian. He was the secretary 
of the Persian prince Mazyar from the Qarinvand dy-
nasty (“katib Mazyar”), who, in 839, guided the rebel-
lion against the Abbasids. This rebellion failed and al-
Tabari converted to Islam, serving as personal physician 
of various Caliphs, including al-Mu’tasim (833-842) 
and al-Mutawakkil (847-861). He cultivated different 
medical disciplines and specialties, including pediatrics 
and pediatric infectious disorders [2-4]. He was the au-
thor of one of the first most comprehensive treatises of 
medical knowledge and pharmacopeia, known as “Fir-
dous al-Hikmah” (“The Paradise of Wisdom”) or “al-
Kunnash”. A chapter of his seven-volume encyclopedia 
was entirely devoted to the description of tuberculosis, 
the etiopathogenesis of which, according to the author, 
should be attributed to the adoption of unhealthy life-
style behaviors, characterized by excessive sexual desire 
and grief. Socio-economic status, such as poverty, could 
as well be a facilitating condition for an increased risk of 
development and/or transmission of tuberculosis. Once 
being infected, the pathogen could erode heart’s veins 
creating cavities. Moreover, al-Tabari described in detail 
tuberculosis cases affecting the skin (lupus vulgaris) as 
well as involving the lymph nodes (Khanazir or scrofu-
la) [4].
Abu Bakr Mohammad Ibn Zakariya Al-Razi, known as 
“Rhazes” (born in Rey, formerly known as Arsacia, Iran, 
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in 854/865 and dead in Rey in 925/930 or 932 accord-
ing to other scholars), compiled a prominent collection 
of medical case-reports and case-series, termed “Kitab 
Al-Hawi Fi Al-Tibb”. In this treatise, the author reported 
a case of a patient who had bloody sputum (nafeth-o-
damm), speculating that the most probable cause was 
pulmonary tuberculosis, in that it rarely occurred in oth-
er pulmonary diseases (such as pleuritis or pneumonia). 
Furthermore, Rhazes was one of the first to describe in 
detail tuberculosis of the joints [5, 6].
In the “Canon of Medicine” (al-QÃnĭn fí al-̸ibb), Avicen-
na, known also as Ibn Sina, Abu Ali Sina or Pur Sina (born 
in Afshona, Uzbekistan, in 980 and dead in Hamadan, Iran, 
in 1037), dedicated two chapters to the description of tu-
berculosis, the fourth and the fifth of his medical encyclo-
pedia addressing, respectively, the etiopathogenesis, the 
differential diagnosis and the pharmacological treatment 
and management of this communicable disorder. Avicenna 
maintained that pulmonary tuberculosis (sil) should be dif-
ferentiated from other respiratory diseases, including pleu-
ritis (zaat al-janb), and asthma (rabv), because all these 
disorders may clinically result, for different etiopathoge-
netic reasons, in cough and shortness of breath. However, 
tuberculosis is uniquely characterized by symptoms such 
as chronic fever that is more severe and relevant at night, 
sweating, sputum that may be bloody (hemoptysis) or con-
tain plaster-like material (lithoptysis), dyspnea, and severe 
weakness, among others. Avicenna added that in advanced 
cases of pulmonary tuberculosis, a potential danger would 
be represented by the insurgence of lung hemorrhage, 
which may ultimately lead to death. Furthermore, from an 
etiopathogenetic standpoint, Avicenna believed that tuber-
culosis has three stages including i) pre-inflammatory, ii) 
ulcerative, and, finally, iii) cavernous stage. According to 
the author, some aggravating factors are seasonality (in par-
ticular, autumn), and eating garlic. Moreover, Avicenna list-
ed 21 potentially beneficial herbs, including plantain (Plan-
tago ovata), grey oak (Quercus baloot), almond (Prunus 
amygdalus), dried sponge, oligochaeta (Volutarella divari-
cata), and opium (Papaver somniferum).
In another famous Persian medical text, “Zakhireh-ye 
Kharazmshahi” (Treasure of Kharazm Shah), Ismail 
Jorjani (born in Urganj, Uzbekistan, in 1040 and dead 
in Chorasmia, Northeastern Iran, in 1136) claimed that 
tuberculosis was a contagious illness characterized by a 
rather prolonged and marked fever.
Modernity and the fight against 
tuberculosis in Iran
During the last decade of the Qajar dynastic period 
(1789-1925) [5], in 1921, the “Pasteur Institute of Iran” 
was established for the proper and effective control of 
tuberculosis. It represented “the most significant medi-
cal establishment partly endowed by waqf” (in Persian 
language, a Muslim religious/charitable foundation cre-
ated by a trust fund) [5]. The first physician who visited 
tuberculosis patients in his private clinic facility was Dr. 
Siavash Shaghaghi, a physician trained in Switzerland 
and an authentic Iranian pioneer in the management and 
treatment of tuberculosis [6, 7].
Another prominent physician in the battle against tu-
berculosis was Dr. Masih Daneshvari (born in 1899 and 
dead in 1976), a pulmonologist that studied in various 
European countries, especially in France, and who, af-
ter a long period of training, returned to Iran in October 
1934 and founded the first Iranian tuberculosis sanitar-
ium, known as “Shah Abad Tuberculosis Patients’ Hos-
pital”. This major healthcare facility, entirely devoted to 
the treatment of tuberculosis patients, was finally settled 
in 1937 due to his efforts. However, due to a shortage of 
healthcare staff, Daneshvari decided in 1939 to write a 
letter to the Prime Minister, in which he explained the 
urgent need to strengthen and considerably expand an 
ambitious tuberculosis control and mitigation program 
at the Shah Abad Tuberculosis Patients’ Hospital. The 
Prime Minister was convinced by this letter and ordered 
the responsible authorities of the Ministries of Interior 
and of Health to provide support to him [6, 7].
Several medical doctors and directors of the Pasteur In-
stitute of Iran have continued these efforts, achieving 
fundamental results in terms of vaccination coverage 
against tuberculosis as well as diagnosis and treatment 
of the disorder. Among these prominent and outstand-
ing professional figures, Dr. Abolhassan ZiyÃ-Zarifi 
(born on 20 August 1926 and dead on 4 October 2010) 
undoubtedly represents the most famous one. He pur-
sued his degree at the School of Pharmacy of Tehran 
University and he started his professional career in 1952 
at the Health Ministry, to later join the academy. His re-
search and clinical interests were mostly represented by 
communicable disorders, and, in particular, respiratory 
infectious diseases, including tuberculosis and legion-
naires’ disease or legionellosis. In 1956, he worked at 
the First tuberculosis diagnostic laboratory supervised 
by Dr. Mehdi Zolriassatian, and, later, he decided to go 
to England in order to strengthen his expertise in the 
field of the clinics of infectious diseases and microbi-
ology. Once returned to Iran, he managed to settle the 
“National Reference tuberculosis Laboratory” in 1963. 
In the same year, Dr. Zia-Zari became a member of the 
“International Union against Tuberculosis and Lung 
Diseases” (IUTLD), of which later he was appointed 
Director. In 1968, Dr. Zia-Zari went abroad to continue 
his training at the Pasteur Institute of Paris and in 1971 
he completed his studies on medical laboratory manage-
ment at the University of Maryland as well as the Cen-
ters for Disease Control and Prevention (CDC) in the 
USA that had been recently founded in 1942. Between 
1975 and 1979, Dr. Zia-Zari was appointed as the Direc-
tor General of the Laboratories of the Ministry of Health 
and during these years with the support of the “World 
Health Organization” (WHO) he was able to establish 
more than 400 medical laboratories, including facilities 
in remote, rural, generally underserved regions of Iran, 
significantly expanding laboratory coverage. 
Due to his strenuous efforts and major achievement, he 
was nominated as a consultant to the WHO in the Middle 
East, Asia and Africa. Furthermore, he wrote several pa-
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pers and books on tuberculosis, including “Bacteriology of 
Tuberculosis” (1973), “A Short History of Robert Koch” 
(1984) and “History of Tuberculosis” (1984)![6,!7].
Tuberculosis in Iran: the current situation 
and future prospects
In Iran, tuberculosis still represents a public health concern, 
with an incidence rate on the rise, because of different fac-
tors, including immigration [8], poor economic-financial 
conditions, co-morbidities (such as diabetes and HIV/
AIDS), high-risk behaviors and unhealthy lifestyles, like 
drug abuse and smoking [9].
Also the incidence of multidrug-resistant (MDR) tubercu-
losis is increasing [10, 11]. According to Jimma and co-
workers [12], the overall pooled prevalence rate of MDR 
tuberculosis in Iran and neighboring countries (including 
Iraq, Turkey and Pakistan) was 16% (with a 95% confi-
dence interval or CI of 11-20%). Having received a previ-
ous tuberculosis treatment, being aged less than 45 years 
and being males were significantly associated with an in-
creased pooled risk of developing MDR tuberculosis with 
an odds-ratio, OR, of 2.01 [95% CI 1.65-2.36%]. 
Despite the efforts, tuberculosis and, in particular, MDR 
tuberculosis still represent a great public health concern 
in Iran. On the other hand, this country can capitalize 
on its millennial, incredibly rich story of major achieve-
ments in the battle against tuberculosis to develop and 
implement ad hoc public health programs for the control 
of the disorder, including targeted and specialized inter-
ventions.
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